Topically Administered Gold Nanoparticles Inhibit Experimental Corneal Neovascularization in Mice
Won‐Kyung Cho, Seungbum Kang, Hyunsu Choi, Chang Rae Rho
Abstract
Won‐Kyung Cho, Seungbum Kang, Hyunsu Choi, Chang Rae Rho
Abstract
PURPOSE: The aim of this study was to evaluate the in vivo effects and mechanism of topically administered gold nanoparticles (AuNP) in a mouse model of corneal neovascularization. METHODS: Inflammatory corneal neovascularization was induced by alkali burns, and the corneas were treated with topical AuNPs. After 1 week, the area of corneal neovascularization was measured using image analysis. The levels of vascular endothelial growth factor receptor 2 and extracellular signal-regulated kinase (ERK1/2) were evaluated by Western blotting. RESULTS: The area of corneal neovascularization was significantly reduced by 39.8% in the AuNP group compared with the control group (P = 0.002). Corneal vascular endothelial growth factor receptor 2 level was higher in the control group than in the AuNP-treated group (P = 0.029). AuNP treatment similarly inhibited burn-induced phosphorylation of ERK (P = 0.029). CONCLUSIONS: Topical administration of AuNPs significantly reduced development of inflammatory corneal neovascularization by inhibiting the ERK pathway.
OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
PURPOSE: The aim of this study was to evaluate the in vivo effects and mechanism of topically administered gold nanoparticles (AuNP) in a mouse model of corneal neovascularization. METHODS: Inflammatory corneal neovascularization was induced by alkali burns, and the corneas were treated with topical AuNPs. After 1 week, the area of corneal neovascularization was measured using image analysis. The levels of vascular endothelial growth factor receptor 2 and extracellular signal-regulated kinase (ERK1/2) were evaluated by Western blotting. RESULTS: The area of corneal neovascularization was significantly reduced by 39.8% in the AuNP group compared with the control group (P = 0.002). Corneal vascular endothelial growth factor receptor 2 level was higher in the control group than in the AuNP-treated group (P = 0.029). AuNP treatment similarly inhibited burn-induced phosphorylation of ERK (P = 0.029). CONCLUSIONS: Topical administration of AuNPs significantly reduced development of inflammatory corneal neovascularization by inhibiting the ERK pathway.
Key concepts: Corneal neovascularization, Neovascularization, MAPK/ERK pathway, Vascular endothelial growth factor, In vivo, Angiogenesis, Medicine, Kinase